Latest Thiophenes Stories
Sales of the LABA/LAMA Combination Drug Class are Expected to Grow Significantly Over the Next Six Months, According to Findings from Decision Resources Group BURLINGTON, Mass., Aug.
-- Results from X-VeRT, the first prospective exploratory study of a Factor Xa inhibitor in patients with atrial fibrillation undergoing cardioversion, will be presented during an ESC Congress 2014
Committee Voted Based on Clinical Data from Eight Efficacy Trials RIDGEFIELD, Conn., Aug. 14, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
The DrugNews Center is the web’s largest source for prescription drug warnings, research and legal news.
Court Documents Indicate a Number of Xarelto Bleeding Lawsuits Have Been Filed In U.S.
The Rottenstein Law Group, a national personal injury law firm, has launched a new website dedicated to providing the public information about the dangers of Xarelto and legal options if they
However, Access Barriers Result in Greater Prescribing of Conventional Anticoagulants, According to Findings from Decision Resources Group BURLINGTON, Mass., July 23, 2014 /PRNewswire/ -- Decision
Zoll, Kranz & Borgess, LLC, (ZKB), an experienced pharmaceutical and medical device litigation firm, is currently investigating claims of individuals who developed bleeding, clotting or other
LONDON, June 26, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Several Xarelto users are considering filing a Xarelto lawsuit after suffering dangerous side effects associated with the popular blood thinner drug Xarelto (rivaroxaban).
- An imitative word; an onomatopoetic word.